Sign Up Today and Learn More About Novome Biotechnologies Stock
Invest in or calculate the value of your shares in Novome Biotechnologies or other pre-IPO companies through EquityZen's platform.
![Novome Biotechnologies](https://dioguwdgf472v.cloudfront.net/media/logos/equityinvest/Company/novomebiotechnologies_logo-3c0239e673183052.png)
Novome Biotechnologies Stock
Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.
About Novome Biotechnologies Stock
Founded
2016
Headquarters
South San Francisco, CA, US
Industries
Software, Data and Analytics, Artificial Intelligence
Novome Biotechnologies Press Mentions
Stay in the know about the latest news on Novome Biotechnologies
Oral administration of genetically engineered bacteria
patents • Apr 14, 2024
Biologically contained bacteria and uses thereof
patents • Apr 14, 2024
Methods and compositions for treating disorders associated with bile acids
patents • Apr 14, 2024
Novome Biotechnologies Appoints Bill McLeod as Chief Financial Officer
biospace • Oct 20, 2021
Scientist, Synthetic Biologist: Novome Biotechnologies – South San Francisco, CA
synbiobeta • Nov 19, 2020
Novome Biotechnologies Management
Leadership team at Novome Biotechnologies
Co-Founder
Zachary Russ
Co-Founder & CSO
Will DeLoache
![Locked Features](https://dioguwdgf472v.cloudfront.net/assets/equityzen/img/public-company/locked-features.png)
Join now and verify your accreditation status to gain access to:
- Novome Biotechnologies current valuation
- Novome Biotechnologies stock price
- Available deals in Novome Biotechnologies and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Novome Biotechnologies stock?
Accredited investors can buy pre-IPO stock in companies like Novome Biotechnologies through EquityZen funds. These investments are made available by existing Novome Biotechnologies shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Novome Biotechnologies stock?
Shareholders can sell their Novome Biotechnologies stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."